Agenus posts Q2 revenue of $34.5M, plans Phase 3 colon cancer trial

August 6, 2026 7:30 AM

Agenus Inc. (Nasdaq: AGEN) reported total revenue of $34.5 million for the second quarter ended June 30, 2026, up from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found